Lung Fibrosis is Seen Reversed in COVID Patients: Says Expert
Chronic Obstructive Pulmonary Disease (COPD) is currently the third leading cause of death globally. There are 300 million current cases of COPD in the...
Monoclonal Antibody Therapy 100% prevents Severe Disease and Deaths, says AIG Hospitals Study
The Monoclonal Antibody drug cocktail gained global attention as a miracle cure for COVID-19 ever since it got administered on ex-US president Donald Trump,...
Mauna Kea Technologies Announces New Clinical Study and Research Collaboration Agreement with the Lung...
Mauna Kea Technologies, inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy platform, announced that it has entered into a new research...
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program...
Medtronic InPen RWD and Extended Infusion Set Pivotal Trial Results Demonstrate Strong Clinical Outcomes...
Medtronic plc, the global leader in medical technology, announced key clinical data from the virtual 81st annual American Diabetes Association Scientific Sessions. The presentations...
The Science of Lung-Gut-Brain Axis in Fighting COVID-19
COVID-19 has, rightfully so, brought a lot of attention to the health of our lungs. We are thinking of increasing - even if not...
A ‘Single Dose’ of vaccine sufficient for those already infected with COVID-19, says AIG...
During the second COVID wave when cases were growing exponentially; unfortunately, the vaccination rate took a downturn. As of 27th April, when the growth...
Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic...
A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood...
BostonGene Announces Cancer Research Collaboration with the Abramson Cancer Center of the University of...
BostonGene Corporation, a biomedical software company committed to defining optimal precision medicine-based therapies for cancer patients, announced a Master Clinical Research Collaboration Agreement with...
Syapse and FDA Expand Existing Research Collaboration to Rapidly Generate Real-World Evidence Related to...
Syapse®, a real-world data company accelerating the delivery of precision medicine through the Syapse Learning Health NetworkTM, and the U.S. FDA Oncology Center of...
